| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | axon guidance receptor activity | 5.37e-05 | 13 | 117 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B CTTNBP2 SPATA31A3 SPATA31A7 GTSE1 OBSCN MIB2 DBN1 SPATA31A6 SPATA31A5 CLIP4 SPTBN5 SPATA31A1 TLN1 CCSER2 COBL KIF2A | 2.25e-04 | 1099 | 117 | 17 | GO:0008092 |
| GeneOntologyBiologicalProcess | axon guidance | EPHB2 GATA3 LGR4 LAMA5 GFRA3 HMCN2 GLI3 WNT3A LRP1 IGSF9 EPHA8 | 6.29e-07 | 285 | 116 | 11 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | EPHB2 GATA3 LGR4 LAMA5 GFRA3 HMCN2 GLI3 WNT3A LRP1 IGSF9 EPHA8 | 6.51e-07 | 286 | 116 | 11 | GO:0097485 |
| GeneOntologyBiologicalProcess | axon development | EPHB2 GATA3 LGR4 LAMA5 DBN1 GFRA3 SCARF1 HMCN2 GLI3 WNT3A LRP1 COBL IGSF9 EPHA8 | 1.51e-05 | 642 | 116 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB2 GATA3 LGR4 LAMA5 DBN1 GFRA3 HMCN2 GLI3 WNT3A LRP1 COBL IGSF9 EPHA8 | 1.81e-05 | 566 | 116 | 13 | GO:0007409 |
| MousePheno | abnormal axial skeleton morphology | HDAC4 OSTM1 GATA3 GATM LAMA5 ANKRD20A3P ANKRD20A8P DBN1 IDS LRIG3 ZNF106 ABHD5 MAST4 ANKRD20A4P LRIG1 WDR11 GLI3 WNT3A SUMF1 SLC6A5 PLA2G6 ANKRD20A1 ALPL | 1.96e-05 | 1458 | 87 | 23 | MP:0002114 |
| Domain | Growth_fac_rcpt_ | 3.68e-08 | 156 | 113 | 10 | IPR009030 | |
| Domain | Ephrin_rec_like | 3.58e-07 | 25 | 113 | 5 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.58e-07 | 25 | 113 | 5 | IPR011641 | |
| Domain | DUF4599 | 6.06e-07 | 12 | 113 | 4 | PF15371 | |
| Domain | DUF4599 | 6.06e-07 | 12 | 113 | 4 | IPR027970 | |
| Domain | EGF_2 | EPHB2 LAMA5 SVEP1 SCARF1 THBD HMCN2 SCUBE2 LRP1 C8A MUC4 EPHA8 | 6.18e-07 | 265 | 113 | 11 | PS01186 |
| Domain | EGF-like_CS | 4.20e-06 | 261 | 113 | 10 | IPR013032 | |
| Domain | Ig-like_fold | EPHB2 TMIGD1 OBSCN KIRREL2 CMYA5 SIGLEC15 SIRPG LRIG3 NPTN HMCN2 LRIG1 MICB IGSF9 KIR2DL4 NFAT5 EPHA8 | 5.34e-06 | 706 | 113 | 16 | IPR013783 |
| Domain | Ank_2 | CTTNBP2 ANKRD20A2P MIB2 ANKRD20A3P CLIP4 ANKRD44 ANKRD20A4P PLA2G6 ANKRD20A1 | 6.37e-06 | 215 | 113 | 9 | PF12796 |
| Domain | Ank | CTTNBP2 ANKRD20A2P MIB2 ANKRD20A3P CLIP4 ANKRD44 ANKRD20A4P PLA2G6 ANKRD20A1 | 1.02e-05 | 228 | 113 | 9 | PF00023 |
| Domain | - | EPHB2 TMIGD1 OBSCN KIRREL2 CMYA5 SIGLEC15 SIRPG LRIG3 NPTN LRIG1 MICB IGSF9 KIR2DL4 NFAT5 EPHA8 | 1.10e-05 | 663 | 113 | 15 | 2.60.40.10 |
| Domain | - | CTTNBP2 ANKRD20A2P MIB2 ANKRD20A3P CLIP4 ANKRD44 ANKRD20A4P PLA2G6 ANKRD20A1 | 2.00e-05 | 248 | 113 | 9 | 1.25.40.20 |
| Domain | Ig_I-set | 2.04e-05 | 190 | 113 | 8 | IPR013098 | |
| Domain | I-set | 2.04e-05 | 190 | 113 | 8 | PF07679 | |
| Domain | EGF-like_dom | 2.06e-05 | 249 | 113 | 9 | IPR000742 | |
| Domain | ANK | CTTNBP2 ANKRD20A2P MIB2 ANKRD20A3P CLIP4 ANKRD44 ANKRD20A4P PLA2G6 ANKRD20A1 | 2.19e-05 | 251 | 113 | 9 | SM00248 |
| Domain | ANK_REPEAT | CTTNBP2 ANKRD20A2P MIB2 ANKRD20A3P CLIP4 ANKRD44 ANKRD20A4P PLA2G6 ANKRD20A1 | 2.34e-05 | 253 | 113 | 9 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | CTTNBP2 ANKRD20A2P MIB2 ANKRD20A3P CLIP4 ANKRD44 ANKRD20A4P PLA2G6 ANKRD20A1 | 2.41e-05 | 254 | 113 | 9 | IPR020683 |
| Domain | ANK_REP_REGION | CTTNBP2 ANKRD20A2P MIB2 ANKRD20A3P CLIP4 ANKRD44 ANKRD20A4P PLA2G6 ANKRD20A1 | 2.41e-05 | 254 | 113 | 9 | PS50297 |
| Domain | EGF_1 | 2.48e-05 | 255 | 113 | 9 | PS00022 | |
| Domain | Ankyrin_rpt | CTTNBP2 ANKRD20A2P MIB2 ANKRD20A3P CLIP4 ANKRD44 ANKRD20A4P PLA2G6 ANKRD20A1 | 3.07e-05 | 262 | 113 | 9 | IPR002110 |
| Domain | Ephrin_rec_like | 3.43e-05 | 11 | 113 | 3 | PF07699 | |
| Domain | IG_LIKE | TMIGD1 OBSCN KIRREL2 SIGLEC15 SIRPG LRIG3 NPTN HMCN2 LRIG1 MICB IGSF9 KIR2DL4 | 4.25e-05 | 491 | 113 | 12 | PS50835 |
| Domain | IG | TMIGD1 OBSCN KIRREL2 SIGLEC15 SIRPG LRIG3 NPTN HMCN2 LRIG1 IGSF9 KIR2DL4 | 4.96e-05 | 421 | 113 | 11 | SM00409 |
| Domain | Ig_sub | TMIGD1 OBSCN KIRREL2 SIGLEC15 SIRPG LRIG3 NPTN HMCN2 LRIG1 IGSF9 KIR2DL4 | 4.96e-05 | 421 | 113 | 11 | IPR003599 |
| Domain | Ig-like_dom | TMIGD1 OBSCN KIRREL2 SIGLEC15 SIRPG LRIG3 NPTN HMCN2 LRIG1 MICB IGSF9 KIR2DL4 | 5.36e-05 | 503 | 113 | 12 | IPR007110 |
| Domain | IGc2 | 9.17e-05 | 235 | 113 | 8 | SM00408 | |
| Domain | EGF_3 | 9.17e-05 | 235 | 113 | 8 | PS50026 | |
| Domain | Ig_sub2 | 9.17e-05 | 235 | 113 | 8 | IPR003598 | |
| Domain | Period_circadian-like_C | 1.08e-04 | 3 | 113 | 2 | IPR022728 | |
| Domain | Period_C | 1.08e-04 | 3 | 113 | 2 | PF12114 | |
| Domain | EGF_CA | 1.75e-04 | 86 | 113 | 5 | PF07645 | |
| Domain | Cortactin-binding_p2_N | 2.16e-04 | 4 | 113 | 2 | IPR019131 | |
| Domain | CortBP2 | 2.16e-04 | 4 | 113 | 2 | PF09727 | |
| Domain | EGF_Ca-bd_CS | 3.07e-04 | 97 | 113 | 5 | IPR018097 | |
| Domain | EGF_CA | 3.37e-04 | 99 | 113 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.54e-04 | 100 | 113 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.62e-04 | 106 | 113 | 5 | IPR000152 | |
| Domain | cEGF | 5.07e-04 | 26 | 113 | 3 | PF12662 | |
| Domain | cEGF | 5.07e-04 | 26 | 113 | 3 | IPR026823 | |
| Domain | EGF | 5.69e-04 | 235 | 113 | 7 | SM00181 | |
| Domain | EGF_CA | 8.76e-04 | 122 | 113 | 5 | SM00179 | |
| Domain | LRRCT | 9.41e-04 | 32 | 113 | 3 | PF01463 | |
| Domain | EGF-like_Ca-bd_dom | 9.43e-04 | 124 | 113 | 5 | IPR001881 | |
| Domain | EGF | 1.01e-03 | 126 | 113 | 5 | PF00008 | |
| Domain | fn3 | 3.05e-03 | 162 | 113 | 5 | PF00041 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 3.15e-03 | 14 | 113 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 3.15e-03 | 14 | 113 | 2 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 3.15e-03 | 14 | 113 | 2 | IPR001426 | |
| Domain | EphA2_TM | 3.15e-03 | 14 | 113 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 3.15e-03 | 14 | 113 | 2 | IPR001090 | |
| Domain | Eph_TM | 3.15e-03 | 14 | 113 | 2 | IPR027936 | |
| Domain | EPH_lbd | 3.15e-03 | 14 | 113 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 3.15e-03 | 14 | 113 | 2 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 3.15e-03 | 14 | 113 | 2 | IPR016257 | |
| Domain | EPH_LBD | 3.15e-03 | 14 | 113 | 2 | PS51550 | |
| Domain | FN3 | 5.36e-03 | 185 | 113 | 5 | SM00060 | |
| Domain | ig | 5.99e-03 | 190 | 113 | 5 | PF00047 | |
| Domain | Immunoglobulin | 5.99e-03 | 190 | 113 | 5 | IPR013151 | |
| Pubmed | 2.69e-12 | 6 | 120 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 2.69e-12 | 6 | 120 | 5 | 25930072 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 9.33e-09 | 8 | 120 | 4 | 12634303 | |
| Pubmed | 1.81e-08 | 24 | 120 | 5 | 32212159 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B DCHS2 CDKN2AIP OBSCN SPATA31A6 DDB1 ZNF106 GRID2IP COBL KIF2A MUC4 | 1.30e-06 | 497 | 120 | 11 | 36774506 |
| Pubmed | 6.83e-06 | 132 | 120 | 6 | 34321664 | ||
| Pubmed | 8.57e-06 | 209 | 120 | 7 | 36779422 | ||
| Pubmed | The lipid droplet-associated protein ABHD5 protects the heart through proteolysis of HDAC4. | 1.18e-05 | 2 | 120 | 2 | 31742248 | |
| Pubmed | Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. | 1.18e-05 | 2 | 120 | 2 | 11799243 | |
| Pubmed | Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. | 1.18e-05 | 2 | 120 | 2 | 11306557 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 20852262 | ||
| Pubmed | Nuclear import of mPER3 in Xenopus oocytes and HeLa cells requires complex formation with mPER1. | 1.18e-05 | 2 | 120 | 2 | 16008569 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 21459569 | ||
| Pubmed | LRP1 is critical for the surface distribution and internalization of the NR2B NMDA receptor subtype. | 1.18e-05 | 2 | 120 | 2 | 23866919 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 33903620 | ||
| Pubmed | Meiotic maturation failure induced by DICER1 deficiency is derived from primary oocyte ooplasm. | 1.18e-05 | 2 | 120 | 2 | 19129368 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 23165628 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 28358367 | ||
| Pubmed | Toll-Like Receptor 2 and Mincle Cooperatively Sense Corynebacterial Cell Wall Glycolipids. | 1.18e-05 | 2 | 120 | 2 | 28483856 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 20101615 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 17962190 | ||
| Pubmed | Polymorphisms in period genes and bone response to hormone therapy in postmenopausal Korean women. | 1.18e-05 | 2 | 120 | 2 | 26624862 | |
| Pubmed | Decreased Dicer expression elicits DNA damage and up-regulation of MICA and MICB. | 1.18e-05 | 2 | 120 | 2 | 18644891 | |
| Pubmed | 1.59e-05 | 153 | 120 | 6 | 10718198 | ||
| Pubmed | 2.21e-05 | 242 | 120 | 7 | 34011540 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GTSE1 INTS1 OBSCN PER1 LAMA5 MIB2 HUWE1 NSD3 NHSL1 TLK1 SUMF1 TLN1 COBL PLA2G6 | 2.89e-05 | 1105 | 120 | 14 | 35748872 |
| Pubmed | Expression profiles of PERIOD1, 2, and 3 in peripheral blood mononuclear cells from older subjects. | 3.53e-05 | 3 | 120 | 2 | 19013183 | |
| Pubmed | A differential response of two putative mammalian circadian regulators, mper1 and mper2, to light. | 3.53e-05 | 3 | 120 | 2 | 9428527 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 26781276 | ||
| Pubmed | Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei. | 3.53e-05 | 3 | 120 | 2 | 9427249 | |
| Pubmed | Genetic analysis of the role of Eph receptors in the development of the mammalian nervous system. | 3.53e-05 | 3 | 120 | 2 | 9321682 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 20923969 | ||
| Pubmed | Association between polymorphisms in period genes and bone density in postmenopausal Korean women. | 3.53e-05 | 3 | 120 | 2 | 24678593 | |
| Pubmed | Photic entrainment of period mutant mice is predicted from their phase response curves. | 3.53e-05 | 3 | 120 | 2 | 20826680 | |
| Pubmed | mPeriod2 Brdm1 and other single Period mutant mice have normal food anticipatory activity. | 3.53e-05 | 3 | 120 | 2 | 29138421 | |
| Pubmed | A time memory engram embedded in a light-entrainable circadian clock. | 3.53e-05 | 3 | 120 | 2 | 37951213 | |
| Pubmed | Influence of age on clock gene expression in peripheral blood cells of healthy women. | 3.53e-05 | 3 | 120 | 2 | 19861640 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 22331899 | ||
| Pubmed | LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers. | 3.53e-05 | 3 | 120 | 2 | 27628597 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 18057099 | ||
| Pubmed | Dicer1 is required for differentiation of the mouse male germline. | 3.53e-05 | 3 | 120 | 2 | 18633141 | |
| Pubmed | Sleep rhythmicity and homeostasis in mice with targeted disruption of mPeriod genes. | 3.53e-05 | 3 | 120 | 2 | 15031135 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 29847800 | ||
| Pubmed | Period determination in the food-entrainable and methamphetamine-sensitive circadian oscillator(s). | 3.53e-05 | 3 | 120 | 2 | 22891330 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 32849922 | ||
| Pubmed | MicroRNA biogenesis is required for mouse primordial germ cell development and spermatogenesis. | 3.53e-05 | 3 | 120 | 2 | 18320056 | |
| Pubmed | Circadian clock regulates hepatic polyploidy by modulating Mkp1-Erk1/2 signaling pathway. | 3.53e-05 | 3 | 120 | 2 | 29269828 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 23869717 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 15894273 | ||
| Pubmed | eek and erk, new members of the eph subclass of receptor protein-tyrosine kinases. | 3.53e-05 | 3 | 120 | 2 | 1648701 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 25344870 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 24323314 | ||
| Pubmed | Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. | 3.53e-05 | 3 | 120 | 2 | 11395012 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 18037903 | ||
| Pubmed | Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity. | 3.53e-05 | 3 | 120 | 2 | 12032351 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 29786747 | ||
| Pubmed | Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. | 3.53e-05 | 3 | 120 | 2 | 15790588 | |
| Pubmed | Evaluation of various endothelial biomarkers in ankylosing spondylitis. | 3.53e-05 | 3 | 120 | 2 | 21556780 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 25550826 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 20338659 | ||
| Pubmed | LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes. | 3.53e-05 | 3 | 120 | 2 | 33469151 | |
| Pubmed | A light-independent oscillatory gene mPer3 in mouse SCN and OVLT. | 3.53e-05 | 3 | 120 | 2 | 9707434 | |
| Pubmed | Intracellular calcium mobilization induces period genes via MAP kinase pathways in NIH3T3 cells. | 3.53e-05 | 3 | 120 | 2 | 11959112 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 32805476 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 11591712 | ||
| Pubmed | The role of phosphorylation and degradation of hPER protein oscillation in normal human fibroblasts. | 3.53e-05 | 3 | 120 | 2 | 14712925 | |
| Pubmed | Making of a Synapse: Recurrent Roles of Drebrin A at Excitatory Synapses Throughout Life. | 3.53e-05 | 3 | 120 | 2 | 28865018 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 36834493 | ||
| Pubmed | 3.73e-05 | 54 | 120 | 4 | 26273529 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HDAC4 GTSE1 NSD3 NHSL1 ZNF106 MAST4 CCSER2 COBL AKAP11 SRPK3 KIF2A CRYBG3 | 4.49e-05 | 861 | 120 | 12 | 36931259 |
| Pubmed | An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. | 7.05e-05 | 4 | 120 | 2 | 11232563 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 20116378 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 10487202 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 10899319 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 23589304 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 19587447 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 14739301 | ||
| Pubmed | Expression of basic helix-loop-helix/PAS genes in the mouse suprachiasmatic nucleus. | 7.05e-05 | 4 | 120 | 2 | 10077321 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 22217103 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 10508692 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 9856466 | ||
| Pubmed | Hippocampal Lnx1-NMDAR multiprotein complex mediates initial social memory. | 7.05e-05 | 4 | 120 | 2 | 31772302 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 25693689 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 30970258 | ||
| Pubmed | Endotoxin Disrupts Circadian Rhythms in Macrophages via Reactive Oxygen Species. | 7.05e-05 | 4 | 120 | 2 | 27168152 | |
| Pubmed | Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. | 7.05e-05 | 4 | 120 | 2 | 15800623 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 33723368 | ||
| Pubmed | KIF21B LAMA5 CTTNBP2NL DICER1 LRIG3 MAST4 CCSER2 IGSF9 AKAP11 | 9.56e-05 | 529 | 120 | 9 | 14621295 | |
| Pubmed | 1.03e-04 | 214 | 120 | 6 | 22199357 | ||
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 23723069 | ||
| Pubmed | Histone monoubiquitination by Clock-Bmal1 complex marks Per1 and Per2 genes for circadian feedback. | 1.17e-04 | 5 | 120 | 2 | 26323038 | |
| Pubmed | Recruitment of histone deacetylase 4 by transcription factors represses interleukin-5 transcription. | 1.17e-04 | 5 | 120 | 2 | 16922677 | |
| Pubmed | Variants in circadian genes and prostate cancer risk: a population-based study in China. | 1.17e-04 | 5 | 120 | 2 | 17984998 | |
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 18332137 | ||
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 9856465 | ||
| Pubmed | Wnt and Bmp signalling cooperatively regulate graded Emx2 expression in the dorsal telencephalon. | 1.17e-04 | 5 | 120 | 2 | 12070081 | |
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 16208538 | ||
| Pubmed | Disturbance of circadian gene expression in hepatocellular carcinoma. | 1.17e-04 | 5 | 120 | 2 | 18444243 | |
| Pubmed | Intercellular coupling confers robustness against mutations in the SCN circadian clock network. | 1.17e-04 | 5 | 120 | 2 | 17482552 | |
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 11865049 | ||
| Interaction | ANKRD20A4P interactions | 3.67e-06 | 6 | 116 | 3 | int:ANKRD20A4P | |
| Interaction | ANKRD20A2P interactions | 6.40e-06 | 7 | 116 | 3 | int:ANKRD20A2P | |
| Interaction | DYNLL2 interactions | CTTNBP2 ANKRD20A2P DDB1 CTTNBP2NL NHSL1 TLK1 ANKRD20A4P CCSER2 ANKRD20A1 | 2.16e-05 | 263 | 116 | 9 | int:DYNLL2 |
| Interaction | ANKRD20A1 interactions | 2.96e-05 | 11 | 116 | 3 | int:ANKRD20A1 | |
| Cytoband | 9p12 | 6.06e-05 | 29 | 120 | 3 | 9p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 1.88e-04 | 8 | 120 | 2 | chr9q12 | |
| Cytoband | 1p36.1-p35 | 2.41e-04 | 9 | 120 | 2 | 1p36.1-p35 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.59e-07 | 161 | 78 | 8 | 593 | |
| GeneFamily | Ankyrin repeat domain containing | CTTNBP2 ANKRD20A2P MIB2 ANKRD20A3P CLIP4 ANKRD44 ANKRD20A4P PLA2G6 ANKRD20A1 | 9.71e-07 | 242 | 78 | 9 | 403 |
| GeneFamily | Fibronectin type III domain containing | 6.40e-04 | 160 | 78 | 5 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 1.48e-03 | 193 | 78 | 5 | 594 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.62e-03 | 14 | 78 | 2 | 1095 | |
| GeneFamily | EF-hand domain containing|Nucleotide excision repair|Transcription and export complex 2 | 2.69e-03 | 18 | 78 | 2 | 1269 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 3.32e-03 | 20 | 78 | 2 | 1371 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | DCHS2 METRNL GATA3 C2CD4A ANKRD20A2P ANKRD20A3P ANKRD20A8P CSMD2 CLIP4 THBD MAST4 MICB WNT3A KCNJ5-AS1 SLC6A5 MKX ANKRD20A1 | 9.37e-06 | 1115 | 117 | 17 | M10371 |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP | 3.21e-05 | 199 | 117 | 7 | M3084 | |
| Coexpression | GSE10325_CD4_TCELL_VS_MYELOID_UP | 3.21e-05 | 199 | 117 | 7 | M3078 | |
| Coexpression | BENPORATH_PRC2_TARGETS | DCHS2 METRNL GATA3 C2CD4A ANKRD20A2P ANKRD20A3P ANKRD20A8P THBD WNT3A SLC6A5 MKX ANKRD20A1 | 3.50e-05 | 650 | 117 | 12 | M8448 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | EPHB2 CTTNBP2 HDAC4 GATA3 HUWE1 IDS CTTNBP2NL GFRA3 NSD3 ANKRD44 LRIG3 THBD GLI3 SORCS2 MKX IGSF9 NFAT5 | 1.24e-06 | 806 | 113 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| ToppCell | COVID-mDC1-|COVID / Condition, Cell_class and T cell subcluster | 4.91e-07 | 175 | 120 | 7 | 83a95d6fc2ddf3ec53f05825bbc982fb8d2ccd15 | |
| ToppCell | COVID-mDC1|COVID / Condition, Cell_class and T cell subcluster | 4.91e-07 | 175 | 120 | 7 | b9280444016e21c28131a61df65cc5c56d402412 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-06 | 199 | 120 | 7 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | mLN-Dendritic_cell-cDC1|mLN / Region, Cell class and subclass | 1.16e-06 | 199 | 120 | 7 | 3e25f096ba69fa43ae08adf9ef194ec7ba463fcf | |
| ToppCell | mLN-(5)_Dendritic_cell-(51)_cDC1|mLN / shred on region, Cell_type, and subtype | 1.16e-06 | 199 | 120 | 7 | 041353e2d06241b98845a288f90339f30ea722dd | |
| ToppCell | Transverse-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 3.45e-06 | 151 | 120 | 6 | 6870f3b5d2bfad849c3203658b5f28f0ae181295 | |
| ToppCell | IIH-mDC1-|IIH / Condition, Cell_class and T cell subcluster | 8.31e-06 | 176 | 120 | 6 | bb80a3e595d071f6cc8b042984b8d9490e377eef | |
| ToppCell | IIH-mDC1|IIH / Condition, Cell_class and T cell subcluster | 8.31e-06 | 176 | 120 | 6 | a75dc132a1061006fd1cb305bd314784fca07ea6 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.15e-06 | 179 | 120 | 6 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD8_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.15e-06 | 179 | 120 | 6 | 4e9e0deabf9b09ffcf30fed6d5eae72ce0ef2f1f | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 9.44e-06 | 180 | 120 | 6 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | mild_COVID-19-NK_CD56bright|mild_COVID-19 / disease group, cell group and cell class (v2) | 9.44e-06 | 180 | 120 | 6 | d8b418edd807a51c0b5f4018b8b478dcc65892a7 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-CD1c-positive_myeloid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-05 | 189 | 120 | 6 | e4b2f00cb3675a4d94e8807d6ff99cc55f9ed233 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.28e-05 | 190 | 120 | 6 | 600b9674197f743dea1d19d3df0fc993b6e6aa25 | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P ANKRD20A8P CTTNBP2NL ANKRD20A4P ANKRD20A1 | 1.36e-05 | 192 | 120 | 6 | bd3d00b094d92463b06023361a71240851a542b8 |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.36e-05 | 192 | 120 | 6 | e24a8856ef01ccf69a5e968bd409f9b84befa91e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-05 | 193 | 120 | 6 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.49e-05 | 195 | 120 | 6 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 198 | 120 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | CTTNBP2 ANKRD20A2P ANKRD20A3P CTTNBP2NL ANKRD20A4P ANKRD20A1 | 1.62e-05 | 198 | 120 | 6 | da84c76afe835aeee39da04b63c03549218b5d91 |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | CTTNBP2 ANKRD20A2P ANKRD20A3P CTTNBP2NL ANKRD20A4P ANKRD20A1 | 1.62e-05 | 198 | 120 | 6 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.62e-05 | 198 | 120 | 6 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Caecum-(5)_Dendritic_cell-(51)_cDC1|Caecum / shred on region, Cell_type, and subtype | 1.67e-05 | 199 | 120 | 6 | 2b97fda45241b2ce7be904cf081cabcf3eb5ba1d | |
| ToppCell | Caecum-Dendritic_cell-cDC1|Caecum / Region, Cell class and subclass | 1.67e-05 | 199 | 120 | 6 | 9ab38a0060a883de6fe3da8cdac42e124d7981d9 | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 2.01e-05 | 122 | 120 | 5 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | (61)_LYVE1_Macrophage|World / shred on Cell_type and subtype | 2.03e-05 | 206 | 120 | 6 | 711e961a9a03bfd2f0958bd14f25f7f207a2f2b5 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.82e-05 | 131 | 120 | 5 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.74e-05 | 152 | 120 | 5 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.93e-05 | 153 | 120 | 5 | cda759ab83a271974651fe4faa21ed4f7ecbb3ae | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.11e-05 | 154 | 120 | 5 | 5967a0a33456d5930fc492a700ebb015ac050abb | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.30e-05 | 155 | 120 | 5 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.32e-05 | 160 | 120 | 5 | c2b5fadb4bac17fafc08831f6d3f4ff96ada7e70 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Cajal-Retzius|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.77e-05 | 162 | 120 | 5 | 1f589a763f3fd4e1e612809ef3903879d47dc1d8 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.99e-05 | 163 | 120 | 5 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | COVID-19_Severe-multiplets|World / disease group, cell group and cell class | 7.99e-05 | 163 | 120 | 5 | 6db4271c2d47a9c333964f36d2c32207115e52cd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.23e-05 | 164 | 120 | 5 | e86899aa68aac572009618c7e017e6734b86357c | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.23e-05 | 164 | 120 | 5 | ed888b55d9c685096fd785878fcb264f4fee88d6 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.22e-05 | 168 | 120 | 5 | 260c768468dff51888f7a68e5424bb174dbaa759 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.22e-05 | 168 | 120 | 5 | 18d7719a76620d5e5698f9ffd08b4ad4cb7c13f8 | |
| ToppCell | COVID-19_Moderate-Treg|World / disease group, cell group and cell class | 9.48e-05 | 169 | 120 | 5 | 27ad11239559b025bef582f89b2a83501d9d3993 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.74e-05 | 170 | 120 | 5 | 81341bf4fe090af70b2091b6b2579ed08d76e22d | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.00e-04 | 171 | 120 | 5 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.00e-04 | 171 | 120 | 5 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | Healthy/Control-MAIT|World / Disease group and Cell class | 1.00e-04 | 171 | 120 | 5 | 61515114b17816a8f9ef6a57262eb9e977b6ede4 | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 174 | 120 | 5 | 44c21521991ad4789783d73d5aa4993a22876886 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 174 | 120 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 174 | 120 | 5 | 46838b4bb9b4d8ce5e1c608a700e7f393bc52658 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-club_cell-club_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 174 | 120 | 5 | 103594eeb600eb5bc9cbf09a65b286b3a3a18cdc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 174 | 120 | 5 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 174 | 120 | 5 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.09e-04 | 174 | 120 | 5 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 175 | 120 | 5 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.12e-04 | 175 | 120 | 5 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.12e-04 | 175 | 120 | 5 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.12e-04 | 175 | 120 | 5 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | (03)_Secretory-(4)_1wkpi|(03)_Secretory / shred by cell type and Timepoint | 1.12e-04 | 175 | 120 | 5 | 06b52f85baa31b55bb31477244892b6da79fe2c9 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 176 | 120 | 5 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | Caecum-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 1.15e-04 | 176 | 120 | 5 | 07cde50e1c18fcc2c5028efe1a087db4ef4d4783 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-04 | 178 | 120 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-04 | 179 | 120 | 5 | dc03b9045510eb1bb934329646bb92dd06890ce9 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-04 | 179 | 120 | 5 | 330c1326ba93bb8f32559ee1cc40e357cc44ad8d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-04 | 180 | 120 | 5 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-04 | 180 | 120 | 5 | 0a98d21fec67a890e75ebf0e2d23adddd77da214 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-04 | 180 | 120 | 5 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-04 | 180 | 120 | 5 | c4068fe47408cfd899131a85fa4b7e5908926f94 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 1.27e-04 | 180 | 120 | 5 | a7db1f00566c9acab8b239cbf2e053fb3f2f6a0d | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-04 | 180 | 120 | 5 | 1c8398342d3fa4d5ca9a8a63626cc497c5291446 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-04 | 180 | 120 | 5 | ddbab26b05f057bd78b78773381cd447bd2e2726 | |
| ToppCell | Control-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 1.27e-04 | 180 | 120 | 5 | 47036eee4c128fbb443d1fc767b4de5cced93f0e | |
| ToppCell | NS-critical-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.31e-04 | 181 | 120 | 5 | cfc3ed541d93158ce26641ea30b7573d93600a11 | |
| ToppCell | Healthy-multiplets|World / disease group, cell group and cell class | 1.31e-04 | 181 | 120 | 5 | f8dbac3cd500cc8d80853312b00d124c27b8fd85 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Control / Disease state, Lineage and Cell class | 1.34e-04 | 182 | 120 | 5 | 31bb838cc2900f3c9da9f835d79d557a08abb928 | |
| ToppCell | wk_15-18-Epithelial-PNS-intermediate_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.38e-04 | 183 | 120 | 5 | d874aa9a856f79626c8a8371f6196a77b7d662ee | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 1.38e-04 | 183 | 120 | 5 | c9e3d91f4c3395a73295b92e25608e0effb5d241 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.38e-04 | 183 | 120 | 5 | 5fb933acfe6bc555c90dba71e75d4be658763945 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.41e-04 | 184 | 120 | 5 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.41e-04 | 184 | 120 | 5 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.41e-04 | 184 | 120 | 5 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.41e-04 | 184 | 120 | 5 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 1.45e-04 | 185 | 120 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | (230)_CD4+/CD25+_Reg_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.45e-04 | 185 | 120 | 5 | f846166cec84985d6a09a45d045acd686174b6d9 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-04 | 186 | 120 | 5 | e0eeef2b9e06324354c5a11a4c6d4c98546f32af | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.48e-04 | 186 | 120 | 5 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.48e-04 | 186 | 120 | 5 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 1.48e-04 | 186 | 120 | 5 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | mLN-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 1.55e-04 | 100 | 120 | 4 | c560326f6ae5338aecdf11ef8adf04bc8769745c | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.56e-04 | 188 | 120 | 5 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 188 | 120 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 188 | 120 | 5 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.56e-04 | 188 | 120 | 5 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | 1.56e-04 | 188 | 120 | 5 | 2331a2bae1383820d598e93aa86c75b101069bac | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.56e-04 | 188 | 120 | 5 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Undetermined|Myeloid_cells / Location, Cell class and cell subclass | 1.60e-04 | 189 | 120 | 5 | b46adb47768a7b6d801c457d7ba65508edfc36a5 | |
| ToppCell | MS-Treg-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 1.60e-04 | 189 | 120 | 5 | b1310eed6113b3536868340a5b2b2587ad377fa9 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Monocytic-Classical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 1.60e-04 | 189 | 120 | 5 | 74a5e61cd820f2495dde40e766c771a31d8c4e7d | |
| ToppCell | MS-Treg|MS / Condition, Cell_class and T cell subcluster | 1.60e-04 | 189 | 120 | 5 | 3fa79242fb3dba4a3f52276da0124ba260423fb6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 190 | 120 | 5 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.64e-04 | 190 | 120 | 5 | 251d50a77e5118a9ad19ea01a7c7c862230ed63c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 190 | 120 | 5 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.64e-04 | 190 | 120 | 5 | cb4cf8ae2156c20b7978ae2e55aa605b4e90f455 | |
| Disease | Schizophrenia | HDAC4 GRIN2B DBN1 CMYA5 CSMD2 DICER1 GFRA3 NPTN WDR11 MICB TLR2 SLC6A5 LRP1 PLA2G6 KIF2A | 8.08e-07 | 883 | 108 | 15 | C0036341 |
| Disease | impotence (is_marker_for) | 1.33e-05 | 2 | 108 | 2 | DOID:1875 (is_marker_for) | |
| Disease | cognitive disorder (is_marker_for) | 1.33e-05 | 2 | 108 | 2 | DOID:1561 (is_marker_for) | |
| Disease | Bicuspid aortic valve | 3.97e-05 | 3 | 108 | 2 | HP_0001647 | |
| Disease | thyroid peroxidase antibody measurement | 1.44e-04 | 72 | 108 | 4 | EFO_0005666 | |
| Disease | amino acid measurement | 1.97e-04 | 678 | 108 | 10 | EFO_0005134 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 1.97e-04 | 6 | 108 | 2 | DOID:13809 (is_marker_for) | |
| Disease | Eosinophilia, Tropical | 2.75e-04 | 7 | 108 | 2 | C0014458 | |
| Disease | response to platinum based chemotherapy, response to antineoplastic agent | 2.75e-04 | 7 | 108 | 2 | EFO_0004647, GO_0097327 | |
| Disease | Eosinophilia | 3.66e-04 | 8 | 108 | 2 | C0014457 | |
| Disease | cognitive disorder (biomarker_via_orthology) | 3.66e-04 | 8 | 108 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | osteoarthritis, spine, body mass index | 3.66e-04 | 8 | 108 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | dentate gyrus volume measurement | 3.96e-04 | 39 | 108 | 3 | EFO_0010083 | |
| Disease | hippocampal CA4 volume | 4.59e-04 | 41 | 108 | 3 | EFO_0009396 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 4.89e-04 | 99 | 108 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | complement C1q subcomponent subunit C measurement | 5.86e-04 | 10 | 108 | 2 | EFO_0801492 | |
| Disease | otitis media (is_marker_for) | 5.86e-04 | 10 | 108 | 2 | DOID:10754 (is_marker_for) | |
| Disease | glycerophosphorylcholine measurement | 7.14e-04 | 11 | 108 | 2 | EFO_0020018 | |
| Disease | tumor necrosis factor beta measurement | 1.35e-03 | 15 | 108 | 2 | EFO_0008308 | |
| Disease | dermatomyositis (is_marker_for) | 1.74e-03 | 17 | 108 | 2 | DOID:10223 (is_marker_for) | |
| Disease | non-word reading | 1.93e-03 | 67 | 108 | 3 | EFO_0005299 | |
| Disease | nevus count | 1.95e-03 | 18 | 108 | 2 | EFO_0004632 | |
| Disease | hippocampal tail volume | 2.18e-03 | 19 | 108 | 2 | EFO_0009398 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 2.25e-03 | 364 | 108 | 6 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | citrulline measurement | 2.42e-03 | 20 | 108 | 2 | EFO_0009777 | |
| Disease | seborrheic dermatitis | 2.42e-03 | 20 | 108 | 2 | EFO_1000764 | |
| Disease | Nystagmus | 2.66e-03 | 21 | 108 | 2 | HP_0000639 | |
| Disease | response to selective serotonin reuptake inhibitor | 3.42e-03 | 82 | 108 | 3 | EFO_0005658 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ENICDSTSSAAAGRL | 401 | Q5TYW2 | |
| ASSCSSNTVVANGKD | 616 | Q9P2B4 | |
| ENICDSTSSAAAGRL | 401 | Q5CZ79 | |
| VLRGSSERTCQANGS | 2866 | Q7Z408 | |
| TQGSSSAAQKRACNT | 71 | P10092 | |
| QASCSSSTTCVRQAQ | 81 | P07357 | |
| AASVNSSGQQCSEAS | 1161 | Q68DQ2 | |
| ENICDSTSSAAAGRL | 401 | Q4UJ75 | |
| VLRSQCDAASQTVTG | 211 | Q9UKA4 | |
| NLSVSCAAASVASSR | 1616 | Q9UPY3 | |
| SATSTANNSRCEGEL | 471 | Q8N3C7 | |
| ECGSSSQRTLSVQEA | 546 | Q9Y2U8 | |
| ENICDSTSSAAAGRL | 401 | Q5SQ80 | |
| QCDCTDSFNVVSTRG | 1001 | O75808 | |
| QTSRVGNSSLEVAGC | 5046 | Q99102 | |
| AICFSTGAQDSSQRA | 56 | Q8N6C7 | |
| SGQLSDTSQTCRVNG | 1406 | P10071 | |
| STAGRSLIEAQTCEN | 1036 | P56524 | |
| SCTAQNSAGSISANA | 671 | Q96JA1 | |
| RSQDGDTAACSLIQA | 1746 | Q8N201 | |
| AATASSRNSCAADDK | 41 | P50440 | |
| ARVDRANSCQSDSSG | 411 | Q6ZRS4 | |
| CTAQNSAGSISANAT | 676 | Q6UXM1 | |
| QAAAGASARACDSVT | 376 | Q96T76 | |
| ECQATNEVGSTSRRA | 1321 | Q8NDA2 | |
| GNSEDESNATCSART | 921 | Q07954 | |
| DGRTCVSNCTASQFV | 3326 | Q07954 | |
| GCVRSATNITCQSSG | 91 | Q8TAV5 | |
| EVCSRTTGQAAAESS | 3426 | Q2LD37 | |
| ERASAQQENSSTCIG | 166 | Q9NXV6 | |
| SAGQRSETRDSSCQT | 256 | Q5SYE7 | |
| INSRTTSEGATNCVC | 291 | P29323 | |
| TSGCSSEQSARARTQ | 121 | O15534 | |
| QGDSTSKQTRSAGCR | 721 | P56645 | |
| QGNAERLSVSSDDSC | 151 | Q8IYA7 | |
| QVISGDACAATSTRA | 1391 | O75037 | |
| VSDSSDQVQACGRAC | 916 | Q9BXB1 | |
| NTLARCSGIASAAAA | 106 | Q15274 | |
| CTSDFAVRGSIQQVT | 201 | Q641Q3 | |
| VSEGNITVTCRASSF | 216 | Q29980 | |
| ACVLAVDENASRSNG | 966 | Q8N8A2 | |
| QQERVASASAGSCDV | 296 | Q16643 | |
| EGRSATCANCTAQSQ | 951 | O15230 | |
| RAAGNTSESQSCARS | 131 | Q86WC4 | |
| CAGNVADATLSAQAT | 876 | Q7Z6Z7 | |
| ESCSSAVGVSNRGVS | 106 | O94916 | |
| ITATNAVDGVASSCR | 591 | A8MWY0 | |
| ESCTAHAASQAATQR | 196 | Q9NYZ3 | |
| SAVARDCSIQGSRST | 2006 | Q6V1P9 | |
| DRDSGSNGQVTCTLT | 376 | Q9Y5I0 | |
| QAEAGASATLSCEVA | 901 | Q5VST9 | |
| AGASATLSCEVAQAQ | 996 | Q5VST9 | |
| NEVRTEAGASATLSC | 1266 | Q5VST9 | |
| EAGASATLSCEVAQA | 1271 | Q5VST9 | |
| EVQAQAGASTTLSCE | 1451 | Q5VST9 | |
| AGASTTLSCEVAQAQ | 1456 | Q5VST9 | |
| AEAGTSATLSCEVAQ | 1546 | Q5VST9 | |
| GASATLSCEVAQAQT | 1641 | Q5VST9 | |
| VRAGENVTLSCSSQS | 136 | Q99706 | |
| SAATERSRCNTTQGN | 131 | P05186 | |
| IGNSCRTSGQTSANA | 416 | O00139 | |
| NSCATRSSSGESLAQ | 191 | Q9H7U1 | |
| RRAGTSCANCQTTTT | 311 | P23771 | |
| ENICDSTSSAAAGRL | 401 | Q5VUR7 | |
| TDSQQAGHRRCSTSN | 6 | Q6PRD7 | |
| QGSFVTNERSSASDC | 716 | A4D2P6 | |
| SNVNTSVALSCTCRG | 306 | O60609 | |
| TCNNTTDSNIGLSAR | 1036 | Q8WZ74 | |
| DSCQASVTQGRAAGQ | 391 | Q8NFT6 | |
| SQTSGVCSREGSTVN | 101 | Q8N3K9 | |
| TAAAAAATCVSAARG | 16 | P29322 | |
| TSDTQACSRELVNGS | 1026 | O75128 | |
| DTSRNCSASTSQGRK | 31 | Q66PJ3 | |
| QINGRSECVDSTDNS | 1041 | O15021 | |
| CEVSNAVGSANRSTA | 291 | Q6UWL6 | |
| ERTACQSESSSAGLA | 96 | Q3LI81 | |
| ASSRGIEACTNAADA | 296 | Q9NV70 | |
| ASCILNVQSRSGDTS | 46 | Q96QF7 | |
| CVALGSETQANSTTD | 21 | P22304 | |
| DLRTQRNATGSAVSC | 6746 | Q8NDH2 | |
| RNATGSAVSCETQIS | 6751 | Q8NDH2 | |
| CSAARLASAQEVAGS | 21 | Q8IYL3 | |
| GATSFQDCETRVQCS | 741 | Q9NQ36 | |
| ARGAKSRTTAACANV | 26 | Q8NCU7 | |
| ASCNSSQVVVAVGRA | 501 | Q16531 | |
| GCRADAINSTQSTAL | 521 | Q96AX9 | |
| NSQRIAAVESCFGAS | 11 | Q96S99 | |
| AANAAATATETTCQD | 21 | Q9NP92 | |
| AALQADGRSCTASAT | 271 | P07204 | |
| DGRSCTASATQSCND | 276 | P07204 | |
| EASFRSAQASCSGAR | 6 | Q9HCN2 | |
| TCTAANSLGRSEASV | 236 | Q6ZMC9 | |
| QNGSSCASRLAANTI | 196 | Q86VY9 | |
| STGAQTFQSADARAC | 56 | Q9Y345 | |
| TARTSCAFNSSVQQD | 286 | Q5VVP1 | |
| TARTSCAFNSSVQQD | 286 | Q8IWB4 | |
| TGDVRVTVQAACGNS | 931 | Q96PQ0 | |
| RGCNVNSTSSAGNTA | 306 | O60733 | |
| SENGNVCQRETASTL | 286 | Q9P1W8 | |
| DFSVNRQVSVSCAEG | 3196 | Q4LDE5 | |
| NTAAARCEQATGACV | 166 | Q14162 | |
| CAARSQNTPDSSASN | 346 | Q8NBK3 | |
| TCTTLARAASARGAQ | 216 | Q9UL12 | |
| TEAAAATAVVRNSRC | 326 | P50452 | |
| SSLERASCGQDQAAA | 766 | Q9NRC6 | |
| ASCSILSGSSNQRET | 361 | Q9UPE1 | |
| ARSCIDGNSGTSIQS | 296 | Q8WTS1 | |
| SSETQCTERGCFSSQ | 6 | Q9ULY5 | |
| ETLVSCSSSGSDQQR | 96 | Q96N06 | |
| TARTSCAFNSSVQQD | 286 | Q5VYP0 | |
| CSVGAKASTNNESSN | 81 | Q9UKI8 | |
| SVCVSSISENDNGIS | 86 | Q6UXZ0 | |
| TARTSCAFNSSVQQD | 286 | Q5TZJ5 | |
| TQGAAERSSSVACSA | 1496 | Q8IWN7 | |
| TARTSCAFNSSVQQD | 286 | Q5VU36 | |
| AAGNSCRQEDVIATA | 2191 | Q9Y490 | |
| LNDTASTDCGTLQSR | 326 | Q86VV4 | |
| CNATNAIGSASVVTV | 316 | Q9Y639 | |
| QNSSQSADGLRCAVS | 56 | Q01081 | |
| CSASNAVARVATSTN | 486 | Q9P2J2 | |
| SKRSSNSSAVNVGFC | 851 | Q9BZ95 | |
| CASASGNAIQARSSS | 11 | O60844 | |
| ASAGVAFAVTRSCAE | 116 | P56704 | |
| SCASAGRDSREAVQA | 271 | Q8N446 | |
| SSSVCVASNAAIQIA | 591 | Q9BXT5 | |
| KSAVCNRNSRNSSSG | 386 | Q9BZH6 | |
| ACLQASRGAQTAAAT | 21 | P21912 | |
| ESSNQASLSCDRNGI | 21 | O60603 | |
| SCTSGAEQNDGQSIR | 1001 | Q9H2Y7 | |
| LSNACSRARDTASGS | 696 | Q9UQQ1 | |
| STTVTGQNSGRQACI | 1226 | Q13224 |